Cannabielsoin
Cannabielsoin (CBE) is a metabolite of cannabidiol, one of the major chemical components of cannabis.[2]
Names | |
---|---|
IUPAC name
(5aS,6S,9R,9aR)-6-methyl-3-pentyl-9-prop-1-en-2-yl-7,8,9,9a-tetrahydro-5aH-dibenzofuran-1,6-diol | |
Other names
| |
Identifiers | |
3D model (JSmol) |
|
Abbreviations | CBE |
ChemSpider | |
KEGG | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C21H30O3 | |
Molar mass | 330.468 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references |
History
Cannabielsoin in scientific journals was first cited in 1973. It was concluded that cannabielsoin was formed from cannabidiol as part of the metabolic process and is non-psychoactive.[3]
References
- "Cannabielsoin (CAS 52025-76-0)". www.caymanchem.com.
- Yamamoto I, Gohda H, Narimatsu S, Watanabe K, Yoshimura H (November 1991). "Cannabielsoin as a new metabolite of cannabidiol in mammals". Pharmacology, Biochemistry, and Behavior. 40 (3): 541–6. doi:10.1016/0091-3057(91)90360-e. PMID 1806944. S2CID 21038637.
- "Cannabielsoin (CBE) Cannabis". Marijuana Doctors.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.